Johnson & Johnson's CEO Bill Weldon testified before a congressional committee today, acknowledging that McNeil Consumer Healthcare should have handled the recall of medicines like Motrin "differently."
What furthermore raised questions about its actions was the decision for the company to buy out defective Motrin medicines although FDA has also been criticized for its knowledge of that plan.
In recent months, Weldon announced that the company was reorganizing its manufacturing unit and named company veteran Ajit Shetty to oversee manufacturing and quality control.
And, The New York Times noted earlier that Weldon had increasingly spoken out that the recalls are not a reflection of problems across the company. In addition, Johnson & Johnson said this week that it plans to reintroduce Liquid Children's Tylenol.
The Wall Street Journal's Heath Blog is updating Thursday's testimonies throughout the day.